Active, Not Recruiting
A Phase III Study to Investigate the Efficacy and Safety of Baxdrostat in Combination With Dapagliflozin on CKD Progression in Participants With CKD and High Blood Pressure.
NCT06268873
- Conditions
- Cardiovascular Diseases, Chronic Disease, Chronic Kidney Disease and Hypertension, +13 more
- Locations
-
- Research Site Fairhope, Alabama, United States
- Research Site Phoenix, Arizona, United States
- Research Site Surprise, Arizona, United States
- Research Site Tucson, Arizona, United States